PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells

Chemotherapy is one of the main therapeutic modalities for cancer patients. Cisplatin (CDDP), as one of the first-line drugs, is of great importance in the chemotherapy of various tumors. However, a significant percentage of cancer patients are resistant to CDDP treatment. Due to the CDDP side effec...

Descripción completa

Detalles Bibliográficos
Autores principales: NAVAEI, ZAHRA NASRPOUR, KHALILI-TANHA, GHAZALEH, ZANGOUEI, AMIR SADRA, ABBASZADEGAN, MOHAMMAD REZA, MOGHBELI, MEYSAM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Tech Science Press 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208004/
https://www.ncbi.nlm.nih.gov/pubmed/37303943
http://dx.doi.org/10.32604/or.2022.025323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10208004/
https://www.ncbi.nlm.nih.gov/pubmed/37303943
http://dx.doi.org/10.32604/or.2022.025323

Ejemplares similares